25 Site Credits
You currently have 0 Site Credits in your account. Purchase Site Credits

Available in Packages/Products: PRESENT Complete Podiatric CME Online

Section: CME Category: General Medicine Medicine & Pharmacology

Review of Pharmacology Part I

Kay Kyllonen,

This is the first of a 2 part pharmacology review by Kay Kyllonen, Pharm. D. Her lecture focuses on medications relevant to the practice of podiatry. These include, among others, anti-diabetic agents, anti-coagulants, NSAIDS, aspirin, glucocorticoids, and gout medications. The indications, mechanisms of action, side effects, and drug interactions of these medications are discussed. Pertinent clinical tips are presented.

CME (Credits: 1.25)

Method of Participation

Complete the 4 steps to earn your CE/CME credit:

  1. Complete the Pre-Test
  2. View the Lecture
  3. Complete the Quiz (Min. 70% Passing Score)
  4. Complete the program Survey
  • Accreditation and Designation of Credits
  • CME (Credits: 1.25)

    PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1.25 continuing education contact hours

    Release Date: 10/08/2020 Expiration Date: 12/31/2022

  • System Requirements
  • To view Lectures online, the following specs are required:

    • Broadband Internet
    • Browsers must have javascript enabled. Most browsers have this feature enabled by default.
    • Any PDF reader. Download Adobe PDF (Free) to print certificates.
    Supported Browsers:
    • Chrome
    • Firefox
    • Microsoft Edge
    • Safari
    Supported Mobile OS:
    • Apple iOS 13+
    • Android 10+
  • Disclosure Information
  • It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.

    ---

    Kay Kyllonen has nothing to disclose